SEC Company Response from Can-Fite BioPharma Ltd. (CANF) (CIK 0001536196) (CANF) — Feb 7, 2020
Can-Fite BioPharma Ltd. (CANF) (CIK 0001536196)
Date: Feb. 7, 2020 · CIK: 0001536196 · Accession: 0001213900-20-002859
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-236064
Referenced dates: February 4, 2020
Letter
Can-Fite BioPharma Ltd.
10 Bareket Street
Kiryat Matalon, P.O. Box 7537
Petach-Tikva 4951778, Israel
February 7, 2020
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Re: Can-Fite BioPharma Ltd.
Withdrawal of Acceleration Request - Registration Statement on Form F-1
File No. 333-236064
VIA EDGAR
Ladies and Gentlemen:
Can-Fite BioPharma Ltd. hereby withdraws its acceleration request letter dated February 4, 2020, which requested that the effective date of the Registration Statement on Form F-1 referenced above be accelerated so that it would have become effective at 9:00 a.m. on February 5, 2020 or as soon thereafter as may be practicable.
Very truly yours,
CAN-FITE BIOPHARMA LTD.
Show Raw Text
CORRESP
1
filename1.htm
Can-Fite BioPharma Ltd.
10 Bareket
Street
Kiryat Matalon,
P.O. Box 7537
Petach-Tikva
4951778, Israel
February 7, 2020
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Re:
Can-Fite BioPharma Ltd.
Withdrawal of Acceleration Request - Registration Statement on
Form F-1
File No. 333-236064
VIA EDGAR
Ladies and Gentlemen:
Can-Fite BioPharma Ltd. hereby withdraws its acceleration request letter dated February 4, 2020, which requested that the effective
date of the Registration Statement on Form F-1 referenced above be accelerated so that it would have become effective at 9:00 a.m.
on February 5, 2020 or as soon thereafter as may be practicable.
Very truly yours,
CAN-FITE BIOPHARMA LTD.
By:
/s/ Pnina Fishman, Ph.D.
Name: Pnina Fishman, Ph.D.
Title: Chief Executive Officer
cc:
Gary Emmanuel (McDermott Will & Emery LLP)